Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)
Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.